Advertisement

Medical Aspects of Gastrointestinal Cancer Etiology, Therapy, and Survivorship

  • Sivaprasad Punnaveetil
  • Preeja Prabhakar
Chapter

Abstract

Cancer is a major public health problem all over the world. Increases in the number of individuals diagnosed with cancer each year, due in large part to aging and growth of the population, as well as improving detection and survival rates, have led to an ever-increasing number of cancer survivors. Various environmental, genetic and dietary factors play a role in cancer causation and prognosis. Advances in our understanding of the cellular and molecular basis of the gastrointestinal (GI) neoplasia have provided a foundation for the development of novel diagnostic and therapeutic approaches.Cancer takes a toll not only on the patients but also on the patients near and dear ones resulting in physical and psychological manifestations in the caregivers. Hence it is essential for the medical fraternity to employ a holistic and multi disciplinary approach in the management of cancer and its sequelae be it physical or psychological.

References

  1. 1.
    Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtrans gastrointestinal and liver diseases. 9th ed. Philadelphia: Saunders; 2010.Google Scholar
  2. 2.
    Hayflick L. Mortality and immortality at the cellular level. A review. Biochemistry. 1997;62:1180–90.PubMedGoogle Scholar
  3. 3.
    Cech TR. Beginning to understand the end of the chromosome. Cell. 2004;116:273–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Thompson TC, Southgate J, Kitchener G, Land H. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell. 1989;56:917–30.CrossRefPubMedGoogle Scholar
  5. 5.
    Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117:1175–83.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194:23–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Ozturk M. p53 mutations in nonmalignant human liver: fingerprints of aflatoxins? Hepatology. 1995;21:600–1.PubMedGoogle Scholar
  9. 9.
    Bortsch H. N-nitroso-compounds and human cancer: where do we stand? IARC Sci Publ. 1991;105:1–10.Google Scholar
  10. 10.
    Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst. 1968;40:43–68.PubMedGoogle Scholar
  11. 11.
    Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med. 1985;313:270–3.CrossRefPubMedGoogle Scholar
  12. 12.
    Barbera L, Seow H, Howell D, et al. Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer. 2010;116:5767–76.CrossRefPubMedGoogle Scholar
  13. 13.
    Patrick DL, Ferketich SL, Frame PS, et al. National Institutes of Health State-of-the Science Panel. National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15–17, 2002. J Natl CancerInst Monogr. 2004;32:9–16.Google Scholar
  14. 14.
    Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer related fatigue: the scale of the problem. Oncologist. 2007;12(1):4–10.CrossRefPubMedGoogle Scholar
  15. 15.
    van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437–49.CrossRefPubMedGoogle Scholar
  16. 16.
    World Health Organization. Cancer pain relief: with a guide to opioid availability. 2nd ed. Geneva, Switzerland: World Health Organization; 1996.Google Scholar
  17. 17.
    National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Adult cancer pain. Version 2.2011. Fort Washington, PA: National Comprehensive Cancer Network; 2011.Google Scholar
  18. 18.
    Tipples K, Robinson A. Optimal management of cancer treatment-induced bone loss: considerations for elderly patients. Drugs Aging. 2011;28:867–83.CrossRefPubMedGoogle Scholar
  19. 19.
    Steinherz LJ, Yahalom J. Cardiactoxicity. In: VT Jr DV, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 6th ed. Philadelphia, PA: Lippincott Williams&Wilkins; 2001. p. 2904–31.Google Scholar
  20. 20.
    Tukenova M, Guibout C, Oberlin O, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol. 2010;28:1308–15.CrossRefPubMedGoogle Scholar
  21. 21.
    Ahles TA, Saykin A. Cognitive effects of standard-dose chemotherapy in patients withcancer. Cancer Investig. 2001;19:812–20.CrossRefGoogle Scholar
  22. 22.
    Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–74.CrossRefPubMedGoogle Scholar
  23. 23.
    Schover LR. Sexuality and fertility after cancer. Hematology Am Soc Hematol Educ Program. 2005:523–7.  https://doi.org/10.1182/asheducation-2005.1.523.
  24. 24.
    Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002;94:39–49.CrossRefPubMedGoogle Scholar
  25. 25.
    Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003;21:1660–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Kushi LH, Byers T, Doyle C, et al. American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2006;56:254–81; quiz 313–314.CrossRefPubMedGoogle Scholar
  27. 27.
    Burke L, Miller LA, Saad A, Abraham J. Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract. 2009;5:6–9.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Yabroff KR, Kim Y. Time costs associated with informal caregiving for cancer survivors. Cancer. 2009;115(18):4362–73.CrossRefPubMedGoogle Scholar
  29. 29.
    Hagedoorn M, Buunk BP, Kuijer RG, Wobbes T, Sanderman R. Couples dealing with cancer: role and gender differences regarding psychological distress and quality of life. Psychooncology. 2000;9:232–42.CrossRefPubMedGoogle Scholar
  30. 30.
    Kim Y, Schulz R, Carver CS. Benefit-finding in the cancer caregiving experience. Psychosom Med. 2007;69:283–91.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Sivaprasad Punnaveetil
    • 1
  • Preeja Prabhakar
    • 2
  1. 1.Department of GastroenterologyStarcare Hospital LLCMuscatOman
  2. 2.Department of Food Science and Nutrition, College of Agricultural and Marine SciencesSultan Qaboos UniversityMuscatOman

Personalised recommendations